This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syneron Medical Ltd (ELOS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 56.69M 63.60M 55.80M 88.64M
Receivables 54.00M 56.94M 55.95M 51.08M
Inventories 49.35M 36.89M 34.71M 36.86M
Other Current Assets 0.00 3.84M 903.00K 1.07M
Total Current Assets 186.17M 201.62M 186.17M 227.46M
Property, Plant & Equipment, Gross 26.04M 21.59M 18.55M 15.81M
Accumulated Depreciation & Depletion 16.22M 14.58M 11.94M 9.66M
Property, Plant & Equipment, Net 9.82M 7.01M 6.60M 6.15M
Intangibles 12.69M 21.70M 21.44M 30.43M
Other Non-Current Assets 36.30M 37.70M 52.37M 11.45M
Total Non-Current Assets 100.62M 105.22M 119.31M 91.64M
Liabilities & Shareholder Equity
Total Assets 286.79M 306.83M 305.48M 319.10M
Accounts Payable 23.05M 21.99M 17.71M 19.94M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 7.85M 5.11M 3.84M 15.64M
Total Current Liabilities 71.84M 68.60M 58.51M 81.80M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 140.00K 2.43M 3.10M
Other Non-Current Liabilities 5.74M 10.13M 12.75M 12.07M
Minority Interest 0.00 0.00 -100.00K -998.00K
Total Non-Current Liabilities 5.74M 10.27M 15.18M 15.52M
Total Liabilities 77.58M 78.87M 73.69M 97.32M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 209.21M 227.97M 231.79M 221.78M
Common Par 91.00K 90.00K 89.00K 86.00K
Additional Paid In Capital 199.05M 193.15M 187.92M 177.47M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 43.29M 49.63M 54.83M 53.19M
Treasury Stock -25.66M -10.07M -9.59M -9.59M
Other Equity Adjustments -7.56M -4.83M -1.47M 626.00K
Total Capitalization 209.21M 227.97M 231.79M 221.78M
Total Equity 209.21M 227.97M 231.79M 221.78M
Total Liabilities & Stock Equity 286.79M 306.83M 305.48M 319.10M
Total Common Shares Outstanding 35.27M 36.75M 36.63M 35.61M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 3.06M 1.30M 1.25M 1.25M
Basic Weighted Shares Outstanding 36.42M 36.70M 35.92M 35.48M
Diluted Weighted Shares Outstanding 36.42M 36.70M 36.20M 35.48M
Number of Employees 784 659 621 651
Number of Part-Time Employees 0 0 0 0
ELOS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ELOS Syneron Medical Ltd

Chart of ELOS

Analysts Ratings for ELOS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ELOS ANALYST REPORT

ELOS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs